{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:46:58Z","timestamp":1780058818771,"version":"3.54.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T00:00:00Z","timestamp":1443052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135723","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T17:48:49Z","timestamp":1443116929000},"page":"e0135723","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge"],"prefix":"10.1371","volume":"10","author":[{"given":"Freek","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hafkemeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Baart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Tolboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Dekking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert","family":"Stittelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Goudsmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Rado\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirikur","family":"Saeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,24]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/MMBR.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"RG Webster","year":"1992","journal-title":"Microbiological reviews"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Toward a universal influenza virus vaccine: prospects and challenges","volume":"64","author":"N Pica","year":"2013","journal-title":"Annual review of medicine"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza A viruses: new research developments","volume":"9","author":"RA Medina","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-3527(09)73002-7","article-title":"Use of Animal Models to Understand the Pandemic Potential of Highly Pathogenic Avian Influenza Viruses","volume":"73","author":"JA Belser","year":"2009","journal-title":"Advances in Virus Research"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"C Hannoun","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref6","unstructured":"WHO. Influenza at the human-animal interface; Summary and assessment as of 4 July 2013. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwwhoint\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_03July13pdf\" xlink:type=\"simple\">http:\/\/wwwwhoint\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_03July13pdf<\/ext-link>."},{"key":"ref7","unstructured":"WHO. Report 9\u2014data in WHO\/HQ as of 12 August 2013. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwwhoint\/influenza\/human_animal_interface\/influenza_h7n9\/09_ReportWebH7N9Numberpdf\" xlink:type=\"simple\">http:\/\/wwwwhoint\/influenza\/human_animal_interface\/influenza_h7n9\/09_ReportWebH7N9Numberpdf<\/ext-link>."},{"issue":"7468","key":"ref8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature12476","article-title":"Limited airborne transmission of H7N9 influenza A virus between ferrets","volume":"501","author":"M Richard","year":"2013","journal-title":"Nature"},{"issue":"6088","key":"ref9","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"S Herfst","year":"2012","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/1951129a0","article-title":"Airborne transmission of influenza virus infection in mice","volume":"195","author":"JL Schulman","year":"1962","journal-title":"Nature"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2006.02421.x","article-title":"Variation and infectivity neutralization in influenza","volume":"119","author":"M Knossow","year":"2006","journal-title":"Immunology"},{"issue":"5808","key":"ref12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/290713a0","article-title":"Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies","volume":"290","author":"W Gerhard","year":"1981","journal-title":"Nature"},{"issue":"13","key":"ref13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"JJ Treanor","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"e49704","DOI":"10.1371\/journal.pone.0049704","article-title":"A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine","volume":"7","author":"RB Couch","year":"2012","journal-title":"PLoS One"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.vaccine.2009.01.116","article-title":"A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine","volume":"27","author":"RJ Cox","year":"2009","journal-title":"Vaccine"},{"issue":"9587","key":"ref16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"I Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.vaccine.2010.12.125","article-title":"Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naive ferrets","volume":"29","author":"B Baras","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1128\/JVI.01939-10","article-title":"Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets","volume":"85","author":"JM van den Brand","year":"2011","journal-title":"J Virol"},{"issue":"45","key":"ref19","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1016\/j.vaccine.2011.08.042","article-title":"Evaluation of a virosomal H5N1 vaccine formulated with Matrix M adjuvant in a phase I clinical trial","volume":"29","author":"RJ Cox","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/515285","article-title":"Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes","volume":"177","author":"S Sambhara","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/cimm.2001.1835","article-title":"Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function","volume":"211","author":"S Sambhara","year":"2001","journal-title":"Cell Immunol"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine","volume":"87","author":"S Rockman","year":"2013","journal-title":"J Virol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/erv.11.25","article-title":"ISCOM technology-based Matrix M adjuvant: success in future vaccines relies on formulation","volume":"10","author":"K Lovgren Bengtsson","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"5958","key":"ref24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/308457a0","article-title":"Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses","volume":"308","author":"B Morein","year":"1984","journal-title":"Nature"},{"issue":"29\u201330","key":"ref25","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1016\/j.vaccine.2008.04.071","article-title":"Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants","volume":"26","author":"K Radosevic","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1750-2659.2011.00256.x","article-title":"Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model","volume":"5","author":"G Pedersen","year":"2011","journal-title":"Influenza Other Respi Viruses"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/jis330","article-title":"T-helper 1 cells elicited by H5N1 vaccination predict seroprotection","volume":"206","author":"GK Pedersen","year":"2012","journal-title":"J Infect Dis"},{"issue":"15","key":"ref28","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/0264-410X(95)00004-K","article-title":"Receptor specificity of influenza virus influences severity of illness in ferrets","volume":"13","author":"MW Leigh","year":"1995","journal-title":"Vaccine"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2007.070248","article-title":"Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals","volume":"171","author":"D van Riel","year":"2007","journal-title":"The American journal of pathology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/clinids\/10.1.56","article-title":"Lessons for human influenza from pathogenicity studies with ferrets","volume":"10","author":"H Smith","year":"1988","journal-title":"Reviews of infectious diseases"},{"issue":"5924","key":"ref31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"DC Ekiert","year":"2009","journal-title":"Science"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"M Throsby","year":"2008","journal-title":"PLoS One"},{"issue":"6044","key":"ref33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"DC Ekiert","year":"2011","journal-title":"Science"},{"issue":"6100","key":"ref34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"C Dreyfus","year":"2012","journal-title":"Science"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2012.02.005","article-title":"Broadly neutralizing antibodies against influenza virus and prospects for universal therapies","volume":"2","author":"DC Ekiert","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"e9106","DOI":"10.1371\/journal.pone.0009106","article-title":"New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets","volume":"5","author":"RH Friesen","year":"2010","journal-title":"PLoS One"},{"key":"ref37","article-title":"Universal Anti-Neuraminidase Antibody Inhibiting all Influenza A Subtypes","author":"TM Doyle","journal-title":"Antiviral Res"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1586\/erv.11.130","article-title":"Influenza viral neuraminidase: the forgotten antigen","volume":"10","author":"BE Johansson","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"MR Sandbulte","year":"2007","journal-title":"PLoS Med"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.3390\/v6062465","article-title":"In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen","volume":"6","author":"TJ Wohlbold","year":"2014","journal-title":"Viruses"},{"key":"ref41","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses","author":"S Jegaskanda","year":"2014","journal-title":"J Infect Dis"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"S Jegaskanda","year":"2013","journal-title":"J Virol"},{"issue":"Suppl 5","key":"ref43","doi-asserted-by":"crossref","first-page":"B17","DOI":"10.1016\/S0264-410X(02)00512-1","article-title":"Inflexal V a trivalent virosome subunit influenza vaccine: production","volume":"20","author":"R Mischler","year":"2002","journal-title":"Vaccine"},{"key":"ref44","article-title":"A Single Immunization With Modified Vaccinia Virus Ankara-Based Influenza Virus H7 Vaccine Affords Protection in the Influenza A(H7N9) Pneumonia Ferret Model","author":"JH Kreijtz","year":"2014","journal-title":"The Journal of infectious diseases"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1086\/651132","article-title":"Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus","volume":"201","author":"JM van den Brand","year":"2010","journal-title":"J Infect Dis"},{"issue":"43","key":"ref46","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1016\/j.vaccine.2013.06.071","article-title":"Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies","volume":"31","author":"JH Kreijtz","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-0934(98)00071-8","article-title":"Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro","volume":"74","author":"GF Rimmelzwaan","year":"1998","journal-title":"Journal of virological methods"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T18:22:20Z","timestamp":1599589340000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135723"}},"subtitle":[],"editor":[{"given":"Florian","family":"Krammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,24]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135723","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,24]]}}}